Keensight Capital acquires majority stake in Bedfont® Scientific Ltd., a global leader in non-invasive breath analysis devices

Sănătate

From Bedfont® Scientific Ltd Oct 14 2025 Keensight Capital (“Keensight”), one of the leading private equity managers dedicated to pan-European Growth Buyou investments, today announced it has acquired a majority stake in Bedfont ® Scientific Ltd. (“Bedfont”), which designs and manufactures non-invasive breath analysis medical devices. As part of the transaction, the Company’s existing shareholders will reinvest alongside Keensight. Founded in 1976 and headquartered in Maidstone, UK, Bedfont is